Which contraceptive method is most effective at preventing both pregnancy and sexually transmitted infections?

Copper intrauterine deviceis a non-hormonallong-acting reversible contraceptive that releases copper ions, creating a spermicidaluterine environment by increasing inflammatory reaction in the endometrium and altering cervical mucus. It is effective for up to 10–12 years, with pregnancy rates <1% per year. Normal menstrual blood loss is 30–40 mL per cycle, and copper IUDs can increase this volume, potentially causing anemia if hemoglobin falls below the normal range of 12–16 g/dL in females.

Rationale for correct answers

1.The copper IUD contains no hormones; contraception is achieved through copper ion release, which is toxic to sperm and ova, preventing fertilization without systemic hormonal effects.

2.Copper IUDs provide long-term contraception for up to 10–12 years, depending on the brand, due to sustained copper ion release maintaining spermicidal activity over time.

4.Copper IUDs have a contraceptive efficacy exceeding 99% due to their continuous local effect on sperm motility and viability, making them among the most effective reversible contraceptive methods.

Rationale for incorrect answers

3.Copper IUDs typically increase, not decrease, menstrual bleeding and cramping, especially in the first months after insertion, due to endometrial inflammation; this contrasts with levonorgestrel IUDs, which can reduce bleeding.

5.Copper IUDs do not require daily monitoring; they only require monthly self-checks for string position and routine medical follow-up, unlike methods such as oral contraceptives that demand daily adherence.

Take home points

• Copper IUDs are hormone-free, highly effective, and long-acting reversible contraceptives.
• They may increase menstrual bleeding and dysmenorrhea.
• Efficacy remains >99% for up to 10–12 years.
• They require minimal maintenance, with only monthly string checks.

Progestin-only contraceptionis preferred during exclusive breastfeedingin the first 6 weeks postpartum to avoid the negative impact of estrogen on milk production. Estrogen suppresses prolactin secretion from the anterior pituitary, which is essential for lactogenesis II. Normal prolactin levels in lactating women range from 100–300 ng/mL during the first 3 months postpartum, supporting milk synthesis and secretion. Progestin-only methods such as the hormonal IUD release levonorgestrel locally, inhibiting fertilization without systemic estrogen exposure, thus preserving lactation while maintaining high contraceptive efficacy (>99%).

Rationale for correct answers

3.A hormonal IUD releases low-dose levonorgestrel directly into the uterine cavity, suppressing sperm motility and thickening cervical mucus without affecting prolactin levels. It is >99% effective, long-acting (3–8 years depending on device), and safe for breastfeeding mothers after 4 weeks postpartum.

Rationale for incorrect answers

1.Combined oral contraceptives contain estrogen, which reduces prolactin secretion and may decrease milk volume, especially within the first 6 weeks postpartum. Estrogen also increases the risk of thromboembolism during this period due to pregnancy-induced hypercoagulability, evidenced by elevated fibrinogen (normal 200–400 mg/dL) and clotting factors.

2.The transdermal contraceptive patch delivers systemic estrogen and progestin, posing the same risks to milk supply and thrombosis as COCs. Its estrogen exposure is continuous, potentially reducing daily milk output by disrupting prolactin-mediated milk synthesis.

4.The vaginal contraceptive ring releases estrogen and progestin, achieving systemic estrogen levels sufficient to impact prolactin. This estrogen exposure during exclusive breastfeeding may compromise milk production and should be avoided in the first 6 weeks postpartum.

Take home points

• Progestin-only methods are preferred for breastfeeding women in the early postpartum period.
• Estrogen-containing contraceptives can suppress prolactin and reduce milk supply.
• Hormonal IUDs provide long-acting, highly effective contraception without estrogen exposure.
• Postpartum hypercoagulability increases estrogen-related thromboembolic risk.